Bone marrow samples for research were obtained from patients with AML according to a study protocol approved by the Cleveland Clinic Institutional Review Board, with written informed consent obtained prior to inclusion in the study. Experiments using patient-derived xenotransplant models of AML were approved by the Cleveland Clinic IACUC.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.